Drug Shortage Report for MYLAN-BUDESONIDE AQ

Last updated on 2020-03-04 History
Report ID 23169
Drug Identification Number 02241003
Brand name MYLAN-BUDESONIDE AQ
Common or Proper name BUDESONIDE AQ
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) BUDESONIDE
Strength(s) 64MCG
Dosage form(s) SPRAY, METERED DOSE
Route of administration NASAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 120
ATC code R01AD
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-10-30
Actual start date 2018-11-05
Estimated end date 2020-03-03
Actual end date 2020-03-03
Shortage status Resolved
Updated date 2020-03-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v35 2017-12-13 English Compare
v34 2017-12-13 English Compare
v33 2017-12-11 French Compare
v32 2017-12-11 English Compare
v31 2017-12-08 French Compare
v30 2017-12-08 English Compare
v29 2017-12-06 French Compare
v28 2017-12-06 English Compare
v27 2017-12-01 French Compare
v26 2017-12-01 English Compare
v25 2017-11-30 French Compare
v24 2017-11-30 English Compare
v23 2017-11-29 French Compare
v22 2017-11-29 English Compare
v21 2017-11-24 French Compare
v20 2017-11-24 English Compare
v19 2017-11-23 French Compare
v18 2017-11-23 English Compare
v17 2017-11-22 French Compare
v16 2017-11-22 English Compare

Showing 61 to 80 of 95